E Garry Menzel
Affiliations
- at Black Diamond Therapeutics Inc. (BDTX), 2025-06-12
- at Stoke Therapeutics Inc. (STOK), 2025-06-05
- Director at Adaptimmune Therapeutics Plc (ADAP), 2024-07-01
- President And Ceo at Tcr2 Therapeutics Inc. (TCRR), 2023-06-01
- Senior Vice President, Finance at Davita Healthcare Partners Inc. (DVA), 2013-09-11
- Coo & Executive Vp, Finance at Regulus Therapeutics Inc. (RGLS), 2012-12-14
Insider Trading: Sales See All
Symbol | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|
ADAP | $0.91 | 47,702 | $43,446.98 | 75,056 | 2023-07-10 | Filing |
TCRR | $1.06 | 11,000 | $11,682.00 | 138,871 | 2022-12-13 | Filing |
TCRR | $1.10 | 10,613 | $11,674.30 | 149,871 | 2022-12-12 | Filing |
TCRR | $1.13 | 10,325 | $11,677.58 | 160,484 | 2022-12-09 | Filing |
TCRR | $1.25 | 9,314 | $11,679.76 | 170,809 | 2022-12-08 | Filing |